Biogen's GAAP net income for 9 months of 2023 was $0.913 billion, down 2.6 times from $2.412 billion in the prior year. Revenue declined 2.4% to $7.449 billion from $7.629 billion a year earlier.
Biogen's GAAP net income for 9 months of 2023 was $0.913 billion, down 2.6 times from $2.412 billion in the prior year. Revenue declined 2.4% to $7.449 billion from $7.629 billion a year earlier. 
investors.biogen.com
English (US) 